Document Detail


Indications for medical treatment of ocular hypertension and the initial use of pilocarpine.
MedLine Citation:
PMID:  7466597     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Ocular hypertension is defined. The decision to initiate treatment depends on the estimate of the benefit to injury ratio with a given treatment and the risk without treatment. Factors that determine our perception of the former are discussed. The key to the latter is the identification and evaluation of the ocular and systemic risk factors for the development of glaucomatous visual field loss. Discussion of these risk factors in the author's clinical practice is presented; overall, approximately 5% of his patients with ocular hypertension are treated. A review of his four-and-a-half year study on uniocular pilocarpine treatment in 59 ocular hypertensive patients is presented. The results suggest that one should be conservative in prescribing pilocarpine.
Authors:
R Z Levene
Related Documents :
7056977 - Care of elderly patients in a special hypertension clinic.
14677147 - The association of psychosocial factors and depression with hypertension among older ad...
17382697 - Adverse metabolic side effects of thiazides: implications for patients with calcium nep...
3530547 - Electrolytes and blood pressure levels in childhood hypertension: measurement and change.
21299547 - Impact of family functioning on quality of life in patients with psychogenic nonepilept...
20624657 - Evaluation of the efficacy and safety of paliperidone extended-release in the treatment...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Survey of ophthalmology     Volume:  25     ISSN:  0039-6257     ISO Abbreviation:  Surv Ophthalmol     Publication Date:    1980 Nov-Dec
Date Detail:
Created Date:  1981-04-21     Completed Date:  1981-04-21     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0404551     Medline TA:  Surv Ophthalmol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  183-7     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Cataract / chemically induced
Drug Therapy, Combination
Echothiophate Iodide / therapeutic use
Glaucoma / drug therapy*
Humans
Intraocular Pressure / drug effects*
Pilocarpine / administration & dosage,  adverse effects,  therapeutic use*
Prognosis
Risk
Chemical
Reg. No./Substance:
513-10-0/Echothiophate Iodide; 92-13-7/Pilocarpine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Retinal vascular accidents in glaucoma and ocular hypertension.
Next Document:  Epinephrine as the initial therapy in selected cases of ocular hypertension.